Yujiro S. Hata

Co-Founder & Chief Executive Officer at IDEAYA Biosciences, Inc.

Yujiro S. Hata

Yujiro S. Hata

Co-Founder & Chief Executive Officer at IDEAYA Biosciences, Inc.

Overview
Career Highlights

Rapt Therapeutics, Inc.
Flexus Biosciences, Inc.
IDEAYA Biosciences, Inc.

RelSci Relationships

801

Number of Boards

5

Birthday

1974

Age

47

Relationships
RelSci Relationships are individuals Yujiro S. Hata likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Arcus Biosciences, Inc.

Relationship likelihood: Strong

General Partner at Canaan Management, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Cidara Therapeutics, Inc.

Relationship likelihood: Strong

Founder & Managing Partner at Wildcat Discovery Technologies, Inc.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Xencor, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at IDEAYA Biosciences, Inc.

Relationship likelihood: Strong

Co-Founder at Zebra Biologics, Inc.

Relationship likelihood: Strong

Investment Director at Roche Ventures

Relationship likelihood: Strong

Senior Vice President & General Counsel at IDEAYA Biosciences, Inc.

Relationship likelihood: Strong

Director of Biology at Aragon Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Yujiro S. Hata
Potential Connections via
Relationship Science
You
Yujiro S. Hata
Co-Founder & Chief Executive Officer at IDEAYA Biosciences, Inc.
Education

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO

Career History
Co-Founder & Chief Executive Officer
2015 - Current

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Chief Operating Officer
2015 - 2015

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Chief Operating Officer
2014 - 2015

Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.

Boards & Committees
Director
Current

Experimed Bioscience, Inc. engages in research and development of drugs. The company was founded by Schepartz Alanna and is headquartered in South San Francisco, CA

Transactions
Details Hidden

IDEAYA Biosciences, Inc. raised money in a private placement transaction

Details Hidden

IDEAYA Biosciences, Inc. raised money in a private placement transaction

Investments
Details Hidden

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Yujiro S. Hata. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Yujiro S. Hata's profile does not indicate a business or promotional relationship of any kind between RelSci and Yujiro S. Hata.